市場調査レポート

商品コード

1745747

レビー小体型認知症治療の世界市場：市場規模・シェア・動向、業界分析 (薬剤の種類別・適応症別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type, Indication, Distribution Channel, and Region - Market Forecast, 2025-2034

出版日: 2025年04月01日
発行: Polaris Market Research
ページ情報: 英文 112 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 618,035円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 763,455円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 908,875円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.42円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のレビー小体型認知症治療の市場規模は2034年までに133億2,000万米ドルに達する見込みです。本レポートでは、現在の市場力学を詳細に洞察し、今後の市場成長に関する分析を提供しています。

レビー小体型認知症治療市場は、脳内の異常なタンパク質沈着によって引き起こされる進行性の神経変性疾患であるレビー小体型認知症（LBD）に関連する症状の管理を目的とした医学的治療と介入に焦点を当てています。レビー小体型認知症は、認知機能低下、運動障害、精神症状、自律神経機能障害を呈し、薬理学的治療と非薬理学的治療の併用が必要となります。コリンエステラーゼ阻害薬、カルビドパ・レボドパ、慎重に投与される抗精神病薬などの薬物療法が一般的に使用される一方、身体的・認知的リハビリテーションなどの支持療法が症状管理に重要な役割を果たします。

この市場は、世界人口の高齢化、神経変性疾患の有病率の増加、診断ツールの進歩による早期発見の向上により成長を遂げています。製薬会社は研究開発に投資しており、臨床試験では治療効果を高めるための新薬候補を探索しています。さらに、認知症研究に対する政府の取り組みや資金提供の増加、医療費の増加も、レビー小体型認知症治療市場に大きなビジネスチャンスをもたらしています。デジタルヘルスソリューション、遠隔医療、個別化医療などの動向は、市場の展望をさらに形成しています。さらに、主要企業間の継続的なイノベーションとコラボレーションが、持続的な成長を促進すると期待されています。

レビー小体型認知症治療市場：分析概要

2024年のレビー小体型認知症治療の市場シェアは、コリンエステラーゼ阻害薬が支配的でした。ドネペジル、リバスチグミン、ガランタミンを含むこれらの薬剤は、コリンエステラーゼという酵素を阻害することで機能し、脳内のアセチルコリン濃度を上昇させる。
2024年には、パーキンソン病がレビー小体型認知症と重複する病態のため市場を席巻し、両方の神経変性疾患に効果的に対処する治療への需要が高まっています。
地域別では、北米がレビー小体型認知症治療市場で最大のシェアを占めたが、これは主に患者数が多いこと、認知度が高まっていること、高度な医療インフラが整備されていることによる。
レビー小体型認知症治療市場では、複数の主要企業が治療オプションの進歩に積極的に貢献しています。これらの企業には、エーザイ、ノバルティス、ファイザー、グラクソ・スミスクライン、ホフマン・ラ・ロシュ、メルク、ジョンソン・エンド・ジョンソン、サノフィ、アッヴィ、アストラゼネカ、ブリストル・マイヤーズスクイブ、イーライリリー・アンド・カンパニー、武田薬品工業、UCB S.A.、大塚製薬が含まれます。

市場スナップショット
レビー小体型認知症治療の市場力学
- 促進要因と機会
  - レビー小体型認知症の有病率の増加
  - 調査と臨床試験の進歩
- 抑制要因と課題
  - 効果的な疾患修飾療法の欠如
PESTLE分析
レビー小体型認知症治療市場の活用動向
バリューチェーン分析
COVID-19の影響分析

第5章世界のレビー小体型認知症治療市場：薬剤の種類別

主な分析結果
イントロダクション
モダフィニル
コリンエステラーゼ阻害剤
ベンゾジアゼピン
抗精神病薬
抗うつ薬
カルビドパ・レボドパ

第6章世界のレビー小体型認知症治療市場：適応症別

主な分析結果
イントロダクション
パーキンソン病
レビー小体型認知症（DLB）

第7章世界のレビー小体型認知症治療市場：流通チャネル別

主な分析結果
イントロダクション
ドラッグストア
病院薬局
オンライン薬局
小売薬局

第8章世界のレビー小体型認知症治療市場：地域別

主な分析結果
イントロダクション
- レビー小体型認知症治療市場の分析：地域別 (2020～2034年)
北米
- 北米：薬剤の種類別（2020～2034年）
- 北米：適応症別（2020～2034年）
- 北米：流通チャネル別（2020～2034年）
- 米国
- カナダ
欧州
- 欧州：薬剤の種類別（2020～2034年）
- 欧州：適応症別（2020～2034年）
- 欧州：流通チャネル別（2020～2034年）
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：薬剤の種類別（2020～2034年）
- アジア太平洋：適応症別（2020～2034年）
- アジア太平洋：流通チャネル別（2020～2034年）
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：薬剤の種類別（2020～2034年）
- 中東・アフリカ：適応症別（2020～2034年）
- 中東・アフリカ：流通チャネル別（2020～2034年）
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
ラテンアメリカ
- ラテンアメリカ：薬剤の種類別（2020～2034年）
- ラテンアメリカ：適応症別（2020～2034年）
- ラテンアメリカ：流通チャネル別（2020～2034年）
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

事業拡大・企業買収の分析
- 事業拡大
- 企業買収
提携/協業/合意/公開

第10章企業プロファイル

AbbVie Inc.
AstraZeneca plc
Bristol-Myers Squibb Company
Eisai Co., Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis AG

図表

List of Tables:

Table 1 Global Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 2 Global Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 3 Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 4 North America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 5 North America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 6 North America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 7 U.S.: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 8 U.S.: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 9 U.S.: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 10 Canada: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 11 Canada: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 12 Canada: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 13 Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 14 Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 15 Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 16 UK: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 17 UK: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 18 UK: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 19 France: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 20 France: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 21 France: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 22 Germany: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 23 Germany: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 24 Germany: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 25 Italy: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 26 Italy: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 27 Italy: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 28 Spain: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 29 Spain: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 30 Spain: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 31 Netherlands: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 32 Netherlands: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 33 Netherlands: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 34 Russia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 35 Russia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 36 Russia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 43 China: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 44 China: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 45 China: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 46 India: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 47 India: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 48 India: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 49 Malaysia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 50 Malaysia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 51 Malaysia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 52 Japan: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 53 Japan: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 54 Japan: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 55 Indonesia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 56 Indonesia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 57 Indonesia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 58 South Korea: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 59 South Korea: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 60 South Korea: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 61 Australia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 62 Australia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 63 Australia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 73 UAE: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 74 UAE: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 75 UAE: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 76 Israel: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 77 Israel: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 78 Israel: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 79 South Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 80 South Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 81 South Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 85 Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 86 Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 87 Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 88 Mexico: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 89 Mexico: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 90 Mexico: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 91 Brazil: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 92 Brazil: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 93 Brazil: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 94 Argentina: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 95 Argentina: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 96 Argentina: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Lewy Body Dementia Treatment Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Drug Type
Figure 7. Global Lewy Body Dementia Treatment Market, by Drug Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Indication
Figure 9. Global Lewy Body Dementia Treatment Market, by Indication, 2024 & 2034 (USD Billion)
Figure 10. Market by Distribution Channel
Figure 11. Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2024 & 2034 (USD Billion)

Product Code: PM1742

The global Lewy body dementia treatment market size is expected to reach USD 13.32 billion by 2034, according to a new study by Polaris Market Research. The report "Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type (Modafinil, Cholinesterase Inhibitors, Benzodiazepine, Antipsychotic Drugs, Antidepressants, and Carbidopa-Levodopa), Indication, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Lewy body dementia treatment market focuses on medical therapies and interventions aimed at managing symptoms associated with Lewy body dementia (LBD), a progressive neurodegenerative disorder caused by abnormal protein deposits in the brain. LBD presents with cognitive decline, movement impairments, psychiatric symptoms, and autonomic dysfunction, requiring a combination of pharmacological and non-pharmacological treatments. Medications such as cholinesterase inhibitors, carbidopa-levodopa, and carefully administered antipsychotics are commonly used, while supportive therapies like physical and cognitive rehabilitation play a crucial role in symptom management.

The market is experiencing growth due to an aging global population, increasing prevalence of neurodegenerative diseases, and advancements in diagnostic tools improving early detection. Pharmaceutical companies are investing in research and development, with clinical trials exploring novel drug candidates to enhance treatment efficacy. Additionally, increasing government initiatives and funding for dementia research, coupled with rising healthcare expenditure, create significant Lewy body dementia treatment market opportunities. Trends such as digital health solutions, telemedicine, and personalized medicine are further shaping the market landscape. Furthermore, ongoing innovations and collaborations among key players are expected to drive sustained growth.

Lewy Body Dementia Treatment Market Report Highlights

Cholinesterase inhibitors dominated the Lewy body dementia treatment market share in 2024. These medications, including donepezil, rivastigmine, and galantamine, function by inhibiting the enzyme cholinesterase, thereby increasing acetylcholine levels in the brain.
In 2024, the Parkinson's disease segment dominated the market due to its overlapping pathology with Lewy body dementia, driving increased demand for treatments that address both neurodegenerative conditions effectively.
By region, North America held the largest share in the Lewy body dementia treatment market, primarily due to a significant patient population, increased awareness, and the availability of advanced healthcare infrastructure.
In the Lewy body dementia treatment market, several key players are actively contributing to advancements in therapeutic options. These companies include Eisai Co., Ltd.; Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Johnson & Johnson; Sanofi S.A.; AbbVie Inc.; AstraZeneca plc; Bristol-Myers Squibb Company; Eli Lilly and Company; Takeda Pharmaceutical Company Limited; UCB S.A.; and Otsuka Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the Lewy body dementia treatment market report on the basis of drug type, indication, distribution channel, and region:

By Drug Type Outlook (Revenue - USD Billion, 2020-2034)

Modafinil
Cholinesterase Inhibitors
Benzodiazepine
Antipsychotic Drugs
Antidepressants
Carbidopa-Levodopa

By Indication Outlook (Revenue - USD Billion, 2020-2034)

Parkinson's Disease
Dementia with Lewy Bodies (DLB)

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Drug Stores
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Lewy Body Dementia Treatment Market Insights

4.1. Lewy Body Dementia Treatment Market - Market Snapshot
4.2. Lewy Body Dementia Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing prevalence of Lewy body dementia
  - 4.2.1.2. Advancements in research and clinical trials
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of effective disease-modifying therapies
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Lewy Body Dementia Treatment Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Lewy Body Dementia Treatment Market, by Drug Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
5.3. Modafinil
- 5.3.1. Global Lewy Body Dementia Treatment Market, by Modafinil, by Region, 2020-2034 (USD Billion)
5.4. Cholinesterase Inhibitors
- 5.4.1. Global Lewy Body Dementia Treatment Market, by Cholinesterase Inhibitors, by Region, 2020-2034 (USD Billion)
5.5. Benzodiazepine
- 5.5.1. Global Lewy Body Dementia Treatment Market, by Benzodiazepine, by Region, 2020-2034 (USD Billion)
5.6. Antipsychotic Drugs
- 5.6.1. Global Lewy Body Dementia Treatment Market, by Antipsychotic Drugs, by Region, 2020-2034 (USD Billion)
5.7. Antidepressants
- 5.7.1. Global Lewy Body Dementia Treatment Market, by Antidepressants, by Region, 2020-2034 (USD Billion)
5.8. Carbidopa-Levodopa
- 5.8.1. Global Lewy Body Dementia Treatment Market, by Carbidopa-Levodopa, by Region, 2020-2034 (USD Billion)

6. Global Lewy Body Dementia Treatment Market, by Indication

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
6.3. Parkinson's Disease
- 6.3.1. Global Lewy Body Dementia Treatment Market, by Parkinson's Disease, by Region, 2020-2034 (USD Billion)
6.4. Dementia with Lewy Bodies (DLB)
- 6.4.1. Global Lewy Body Dementia Treatment Market, by Dementia with Lewy Bodies (DLB), by Region, 2020-2034 (USD Billion)

7. Global Lewy Body Dementia Treatment Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Drug Stores
- 7.3.1. Global Lewy Body Dementia Treatment Market, by Drug Stores, by Region, 2020-2034 (USD Billion)
7.4. Hospitals Pharmacies
- 7.4.1. Global Lewy Body Dementia Treatment Market, by Hospitals Pharmacies, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacies
- 7.5.1. Global Lewy Body Dementia Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
7.6. Retail Pharmacies
- 7.6.1. Global Lewy Body Dementia Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)

8. Global Lewy Body Dementia Treatment Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Lewy Body Dementia Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Lewy Body Dementia Treatment Market - North America
- 8.3.1. North America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
- 8.3.3. North America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Lewy Body Dementia Treatment Market - U.S.
  - 8.3.4.1. U.S.: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Lewy Body Dementia Treatment Market - Canada
  - 8.3.5.1. Canada: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Lewy Body Dementia Treatment Market - Europe
- 8.4.1. Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
- 8.4.3. Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Lewy Body Dementia Treatment Market - UK
  - 8.4.4.1. UK: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Lewy Body Dementia Treatment Market - France
  - 8.4.5.1. France: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Lewy Body Dementia Treatment Market - Germany
  - 8.4.6.1. Germany: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Lewy Body Dementia Treatment Market - Italy
  - 8.4.7.1. Italy: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Lewy Body Dementia Treatment Market - Spain
  - 8.4.8.1. Spain: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Lewy Body Dementia Treatment Market - Netherlands
  - 8.4.9.1. Netherlands: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Lewy Body Dementia Treatment Market - Russia
  - 8.4.10.1. Russia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Lewy Body Dementia Treatment Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Lewy Body Dementia Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Lewy Body Dementia Treatment Market - China
  - 8.5.4.1. China: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Lewy Body Dementia Treatment Market - India
  - 8.5.5.1. India: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Lewy Body Dementia Treatment Market - Malaysia
  - 8.5.6.1. Malaysia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Lewy Body Dementia Treatment Market - Japan
  - 8.5.7.1. Japan: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Lewy Body Dementia Treatment Market - Indonesia
  - 8.5.8.1. Indonesia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Lewy Body Dementia Treatment Market - South Korea
  - 8.5.9.1. South Korea: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Lewy Body Dementia Treatment Market - Australia
  - 8.5.10.1. Australia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Lewy Body Dementia Treatment Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Lewy Body Dementia Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Lewy Body Dementia Treatment Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Lewy Body Dementia Treatment Market - UAE
  - 8.6.5.1. UAE: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Lewy Body Dementia Treatment Market - Israel
  - 8.6.6.1. Israel: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Lewy Body Dementia Treatment Market - South Africa
  - 8.6.7.1. South Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Lewy Body Dementia Treatment Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Lewy Body Dementia Treatment Market - Latin America
- 8.7.1. Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Lewy Body Dementia Treatment Market - Mexico
  - 8.7.4.1. Mexico: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Lewy Body Dementia Treatment Market - Brazil
  - 8.7.5.1. Brazil: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Lewy Body Dementia Treatment Market - Argentina
  - 8.7.6.1. Argentina: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Lewy Body Dementia Treatment Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. AbbVie Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AstraZeneca plc
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Bristol-Myers Squibb Company
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Eisai Co., Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Eli Lilly and Company
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. F. Hoffmann-La Roche Ltd
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. GlaxoSmithKline plc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Johnson & Johnson
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Merck & Co., Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Novartis AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

レビー小体型認知症治療の世界市場：市場規模・シェア・動向、業界分析 (薬剤の種類別・適応症別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type, Indication, Distribution Channel, and Region - Market Forecast, 2025-2034

レビー小体型認知症治療市場：分析概要

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章世界のレビー小体型認知症治療市場の洞察

第5章世界のレビー小体型認知症治療市場：薬剤の種類別

第6章世界のレビー小体型認知症治療市場：適応症別

第7章世界のレビー小体型認知症治療市場：流通チャネル別

第8章世界のレビー小体型認知症治療市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Lewy Body Dementia Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Lewy Body Dementia Treatment Market Insights

5. Global Lewy Body Dementia Treatment Market, by Drug Type

6. Global Lewy Body Dementia Treatment Market, by Indication

7. Global Lewy Body Dementia Treatment Market, by Distribution Channel

8. Global Lewy Body Dementia Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

レビー小体型認知症治療の世界市場：市場規模・シェア・動向、業界分析 (薬剤の種類別・適応症別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type, Indication, Distribution Channel, and Region - Market Forecast, 2025-2034

レビー小体型認知症治療市場：分析概要

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界のレビー小体型認知症治療市場の洞察

第5章 世界のレビー小体型認知症治療市場：薬剤の種類別

第6章 世界のレビー小体型認知症治療市場：適応症別

第7章 世界のレビー小体型認知症治療市場：流通チャネル別

第8章 世界のレビー小体型認知症治療市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Lewy Body Dementia Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Lewy Body Dementia Treatment Market Insights

5. Global Lewy Body Dementia Treatment Market, by Drug Type

6. Global Lewy Body Dementia Treatment Market, by Indication

7. Global Lewy Body Dementia Treatment Market, by Distribution Channel

8. Global Lewy Body Dementia Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章世界のレビー小体型認知症治療市場の洞察

第5章世界のレビー小体型認知症治療市場：薬剤の種類別

第6章世界のレビー小体型認知症治療市場：適応症別

第7章世界のレビー小体型認知症治療市場：流通チャネル別

第8章世界のレビー小体型認知症治療市場：地域別

第9章競合情勢

第10章企業プロファイル